S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

EYPT EyePoint Pharmaceuticals Inc

8.82

0.00 (0.00%)

Jan 23 2025 - Closed

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

EyePoint Pharmaceuticals (NASDAQ:EYPT)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more EyePoint Pharmaceuticals Charts.

EyePoint Pharmaceuticals (NASDAQ:EYPT)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more EyePoint Pharmaceuticals Charts.

EyePoint Pharmaceuticals Inc News

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Thursday 16 January 2025 (1 week ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 13 January 2025 (2 weeks ago) • Edgar (US Regulatory)

EyePoint Provides Company Update and Anticipated Development Milestones for 2025
Monday 13 January 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 8 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 8 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 8 January 2025 (2 weeks ago) • Edgar (US Regulatory)

EyePoint Appoints Renowned Retina Specialist and Industry Pioneer Reginald J. Sanders, M.D., FASRS to Board of Directors
Wednesday 8 January 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 7 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 7 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 7 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 7 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 7 January 2025 (2 weeks ago) • Edgar (US Regulatory)

More EyePoint Pharmaceuticals Inc News Articles

Proact It Group Ab

MDK Acquisition

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions